Persistent central inflammation and region specific cellular activation accompany depression-and anxiety-like behaviours during the resolution phase of experimental …

E Dempsey, A Abautret-Daly, NG Docherty… - Brain, behavior, and …, 2019 - Elsevier
Depression and anxiety-related psychological symptoms are increasingly recognised as
important co-morbidities in patients with inflammatory bowel disease (IBD). Dextran sulfate …
被引用次数：52 相关文章

[引用][C] Persistent central inflammation and region specific cellular activation accompany depression-and anxiety-like behaviours during the resolution phase of …

E Dempsey, Á Abautret-Daly, A Harkin… - Brain, Behavior, and …, 2019 - elibrary.ru
This work was supported by the EU-FP7 MOODINFLAME consortium and partly funded by
Science Foundation Ireland (SFI)[SFI-RFP/BMT2781 to CM]. AAD was also funded by a …

[引用][C] Persistent central inflammation and region specific cellular activation accompany depression-and anxiety-like behaviours during the resolution phase of …

E Dempsey, Á Abautret-Daly, NG Docherty… - Brain, Behavior, and …, 2019 - cir.nii.ac.jp
Persistent central inflammation and region specific cellular activation accompany depression-
and anxiety-like behaviours during the resolution phase of experimental colitis | CiNii …

Persistent central inflammation and region specific cellular activation accompany depression-and anxiety-like behaviours during the resolution phase of experimental …

E Dempsey, Á Abautret-Daly, NG Docherty… - Brain, Behavior, and …, 2019 - europepmc.org
Depression and anxiety-related psychological symptoms are increasingly recognised as
important co-morbidities in patients with inflammatory bowel disease (IBD). Dextran sulfate …

Persistent central inflammation and region specific cellular activation accompany depression-and anxiety-like behaviours during the resolution phase of experimental …

E Dempsey, Á Abautret-Daly… - Brain, behavior …, 2019 - pubmed.ncbi.nlm.nih.gov
Depression and anxiety-related psychological symptoms are increasingly recognised as
important co-morbidities in patients with inflammatory bowel disease (IBD). Dextran sulfate …